Release date: 2008-12-03 The researchers cultivated porcine chondrocytes in a controlled laboratory environment, then extracted key biological components such as proteins and other active substances found in cartilage tissue. These materials were used to develop a novel biomaterial capable of promoting the regeneration of human tissues, particularly articular cartilage. More importantly, they also created a safe and effective method for transplanting this material into patients. The newly developed biomaterial is a combination of fibrin and hyaluronic acid, both of which are known for their strong compatibility with chondrocytes. This unique formulation significantly enhances the effectiveness of bone marrow stimulation techniques. The team observed that when chondrocytes were introduced into the mixture, they formed high-quality cartilage tissue. Even without the addition of transforming growth factor (TGF-β), the material was able to induce cartilage differentiation when combined with bone marrow mesenchymal stem cells. To further improve the mechanical strength and stability of the material, the researchers coated it with an alginate layer. This innovation made the biomaterial suitable for real-world clinical use. The material can be molded into various forms, such as granules or flakes, making it highly adaptable for different treatment scenarios. Recognizing its potential, the researchers named the material “Art Prove.†This breakthrough not only represents a significant advancement in regenerative medicine but also highlights the growing role of cross-species biomaterials in modern medical treatments. As the field continues to evolve, such innovations may pave the way for more effective and accessible therapies for joint-related conditions. — Shanghai Medical Device Industry Association Bedsore Cushion,Bed Sore Pads,Anti Bedsore Cushion,Bedsore Cushions Hebei Dingli Medical Equipment Co., Ltd. , https://www.dinglimed.com
A groundbreaking development in cartilage repair has emerged from a research team in South Korea, who have successfully translated their work from the lab to clinical application. The Cell Therapy Center at the Korean Medical School of Asia University has achieved a global first by using biomaterials derived from porcine chondrocytes to support tissue regeneration in patients. This innovative approach could offer new hope for those suffering from joint damage and osteoarthritis.
Korean pig cartilage cells made of biological materials
Prev Article
How to ensure safe wintering of sheep